Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Diabetes Patients are Being Tested with AI for Blindness in Non-Eye Care Settings

February 14, 2019 By Tierney King

Patients diagnosed with diabetes are now having their eyes checked for a leading cause of blindness using AI. IDx-DR, an FDA-cleared AI system, can detect diabetic retinopathy and doesn’t require a physician to interpret the images or results. This means patients who are at high risk for the blinding eye disease can be tested in non-eye care settings.

Previously, Madhu Mohan, MD, an endocrinologist at Riverside Medical Associates, did not have the ability to test his patients for diabetic retinopathy without first referring them to an eye care facility. Like many healthcare provides, many of his patients did not go to their annual eye exam, and he was worried some of his patients were developing blindness, yet not being tested. Now, Mohan can use the device to test his patients during regularly scheduled visits.

“In the short time we’ve been using IDx-DR, we’ve already identified patients we believe may have disease that has gone undetected for years. This is a bomb shell – a truly eye-opening experience – that helped confirm my decision to adopt the system,” said Dr. Mohan. “There is an enormous care gap we can’t ignore.”

Over 30 million Americans have diabetes, and approximately 24,000 lose their vision from diabetic retinopathy. If caught in the early stages, vision loss and blindness are almost entirely preventable, yet only about half of people diagnosed with diabetes get annual eye exams.

Now, a diabetes education center at a hospital in New Orleans, LA has also adopted IDx-DR to test for diabetic retinopathy. Their goal is to increase the number of patients they test from 10 to 13 to over 20 a day.

Currently, IDx-DR is used in the following care settings:

  • Endocrinology clinics
  • Internal medicine clinics
  • Diabetes education centers
  • Diagnostic labs
  • Community health clinics
  • Diabetes research groups

“It is exciting to see such a wide range of healthcare settings – most who were previously unable to provide eye care services – now using an autonomous AI system to test patients for diabetic retinopathy, without needing the involvement of telemedicine or an eye care specialist,” said Michael Abramoff, MD, PhD, founder and CEO of IDx. “We need to make it easier for patients to be tested and that means meeting them where they are already receiving their care. IDx-DR can be placed in whatever setting that might be.”

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
Americares Ukraine relief
Americares sending 100 tons of medical supplies to Ukraine
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies
DTBoston22_keynote_Petrovic-Web-MD
How Insulet created its next-gen Omnipod 5

DeviceTalks Weekly.

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech